Discover who Danaher is
At Danaher, our commitment to a healthier, more sustainable tomorrow is a critical part of who we are. We work to save lives by helping discover, develop and deliver innovative healthcare solutions.

mRNA expertise
mRNA is once again sparking global attention for its possibilities. It gave us a breakthrough vaccine to fight COVID-19. But future applications, especially in drug development, have even greater potential to prevent and treat some of the world’s most critical health challenges, from malaria to cancer to rare genetic disorders.

CRISPR-based therapies
The continued development of CRISPR-based therapies could soon stall out with treatment options delayed unless industry, academia, and government work together to design new scientific and regulatory models. With this challenge in mind, Danaher is building a collaborative center with the Innovative Genomics Institute (IGI).
Discover why
Innovation begins with a spark of curiosity and the drive to tackle challenging questions. At Danaher, we’re committed to investing in groundbreaking academic research. We work with leading science and technology experts to develop cutting-edge solutions to improve human health.

AI and digital pathology
Integrating advanced technology and AI-driven tools to enhance disease diagnosis is revolutionizing digital pathology. This approach enables remote case review, consultation, and robust image analysis. But why should we support pathologists, allowing them to focus on critical diagnostics while AI handles data analysis and more?

See how it works
Danaher’s Beacons program focuses on collaborating with top academic researchers and institutions to drive R&D, leveraging unique expertise to create scientific breakthroughs that improve human health. By partnering with leading universities and research institutions we aim to fuel advancements in science and technology.




Focused on scientific excellence, innovation and sustainability, Danaher partners closely with customers, organizations and institutions to help solve many important health challenges impacting patients.
Our relationships in the industry uniquely position us to streamline manufacturing and reduce the time and cost to develop life-changing therapies.

The pace of scientific innovation is faster than ever and provides endless possibilities to make an impact.
Danaher and our businesses focus on genomic medicine, early diagnoses and precision medicine, protein science, scalable R&D and next-gen biomanufacturing – all cutting-edge fields where Danaher is uniquely poised to drive progress.

Thanks to our industry-leading operating companies, we offer access to technology and expertise across a broad portfolio – united by the continuous improvement model of the Danaher Business System.
We work together to advance the development of ground-breaking products and end-to-end solutions for healthcare’s biggest challenges.
We’re accelerating the power of science and technology across our platforms – Biotechnology, Diagnostics and Life Sciences.
Biotechnology
We help our customers discover and deliver the next generation of patient therapeutics. Leveraging our scale and reach, our portfolio supports customers - spanning researchers, large-scale biopharmaceutical and contract manufacturers - to manufacture end-to-end solutions rapidly, securely and sustainably.
Diagnostics
We enable the real-life adoption of new diagnostic innovations through our proven practices, advanced tools and integrated solutions. By understanding customer priorities and ensuring our solutions meet their needs, we focus on delivering results to patients sooner and empowering doctors to diagnose faster.
Life Sciences
We empower our customers through cutting-edge research and development and contribute to people living longer, happier lives. Using our unprecedented technical expertise, we help further their understanding of disease and infection, develop therapies and vaccines, and test treatments with accelerated impact.